Before the bell rings, see which businesses are in the news.
Abercrombie & Fitch Notwithstanding the clothing retailer’s excellent holiday guidance and earnings beat, shares fell by almost 4%.
Best Buy – After Best Buy reported third-quarter earnings that fell short of analyst estimates and lowered its full-year sales outlook, shares fell 7.4%.
Kohl’s – Following the retailer’s lower-than-expected third-quarter earnings, shares fell by about 17%.
Stellantis After President-elect Donald Trump announced his intention to increase tariffs on goods from China, Mexico, and Canada in a Truth Social post on Monday, shares of European and Japanese automakers fell.
Dick’s Sporting Goods: After the company’s quarterly results exceeded forecasts and showed a promising outlook for the holiday shopping season, shares of the sporting goods retailer surged 6.6%.
Zoom Video Communications: After the video software company provided projections for fiscal fourth-quarter adjusted earnings per share that was essentially in line with forecasts, shares fell about 10.5%. But Zoom’s fiscal third-quarter revenue and earnings above Wall Street’s projections.
Amgen — After the business reported that its experimental weight-loss medication helped patients drop up to 20% of their body weight after a year, shares declined more than 3%. On the other hand, the trial results seemed to fall short of what investors had anticipated.
Rivian Automobiles. Following the company’s announcement that it had gotten conditional approval for a government loan of up to $6.6 billion to support its production capacity, including the development of its Georgia EV factory, shares of the electric car manufacturer increased by almost 9%.
Fluence Energy: After the company’s fourth-quarter revenue fell short of forecasts, the energy storage stock dropped almost 4%.
Mayo Clinic, Eli Lilly — Pharmaceutical companies’ shares The Biden administration’s proposed rule that Medicare and Medicaid will pay for expensive weight-loss medications for obese Americans caused Novo Nordisk and Eli Lilly to rise more than 2.5% and 4.7%, respectively.
Source (CNBC)
